Aladdin Scientific
Grisnilimab (anti-CD7) (C007B-553970)
Grisnilimab (anti-CD7), a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab (anti-CD7) regulates the transcription of multiple target genes and may participate in the post-transcriptional
Grisnilimab (anti-CD7), a monoclonal antibody anti-CD7, is a tumor suppressor involved in the etiology of Wilms' tumor. Grisnilimab (anti-CD7) regulates the transcription of multiple target genes and may participate in the post-transcriptional processing of RNA.
Specification: Carrier Free, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB191904-SCI_302fcfb614811a37e2a67d01fd12c24e.pdf
- UPC:
- 51112004
- Condition:
- New
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- Ab191904-100μg
- CAS:
- 2367001-70-3
- Product Size:
- 100μg



